UK hospitals in more hot water over wait list distortion
This article was originally published in Clinica
Executive Summary
An investigation into waiting list manipulation at UK NHS hospitals has revealed "serious mismanagement" at the Royal United Hospitals, Bath. The medical technology industry has good reason to monitor the government's drive to tackle the problem, which is said to have "skewed the national picture-of real progress". Seen as a key NHS performance indicator, hospital waiting times and numbers carry enormous political weight and are a major force behind moves to increase throughput, notably by investing in diagnostic and therapy facilities and in specialised personnel to operate these.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.